A double-blind placebo-controlled cross-over clinical trial of DONepezil In Posterior cortical atrophy due to underlying Alzheimer's Disease: DONIPAD study

BACKGROUND: The study investigated whether donepezil exerts symptomatic benefit in patients with posterior cortical atrophy (PCA), an atypical variant of Alzheimer’s disease. METHODS: A single-centre, double-blind, placebo-controlled, cross-over clinical trial was performed to assess the efficacy of...

Full description

Saved in:
Bibliographic Details
Published in:Alzheimers Res Ther
Main Authors: Ridha, Basil H., Crutch, Sebastian, Cutler, Dawn, Frost, Christopher, Knight, William, Barker, Suzie, Epie, Norah, Warrington, Elizabeth K., Kukkastenvehmas, Riitta, Douglas, Jane, Rossor, Martin N.
Format: Artigo
Language:Inglês
Published: BioMed Central 2018
Subjects:
Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5930935/
https://ncbi.nlm.nih.gov/pubmed/29716655
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-018-0363-1
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items